Göppner, D., J. Müller, S. Krüger, I. Franke, H. Gollnick, and S. R. Quist. “High Incidence of Naevi-Associated BRAF Wild-Type Melanoma and Dysplastic Naevi under Treatment With the Class I BRAF Inhibitor Vemurafenib”. Acta Dermato-Venereologica, vol. 94, no. 5, Feb. 2014, pp. 517-20, doi:10.2340/00015555-1813.